These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6350348)

  • 1. Disk agar diffusion susceptibility testing with 30-micrograms ceftazidime disks: confirmation of interpretive breakpoints and quality control guidelines.
    Jones RN; Barry AL; Thornsberry C
    J Clin Microbiol; 1983 Jul; 18(1):211-4. PubMed ID: 6350348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefpirome (HR810) disk diffusion susceptibility tests: confirmation of interpretive criteria using cefotaxime and cefoperazone-resistant strains and effects of blood supplemented media.
    Jones RN; Barry AL; Thornsberry C
    Diagn Microbiol Infect Dis; 1986 Apr; 4(4):345-9. PubMed ID: 3698547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits.
    Jones RN; Gavan TL; Barry AL; Thornsberry C; Gibbs DL
    J Clin Microbiol; 1982 May; 15(5):777-86. PubMed ID: 6212596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria.
    Fuchs PC; Jones RN; Barry AL; Gavan TL
    J Clin Microbiol; 1989 Jan; 27(1):49-52. PubMed ID: 2492304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporin.
    Jones RN; Barry AL
    J Clin Microbiol; 1987 Nov; 25(11):2211-3. PubMed ID: 3121667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aztreonam: antibacterial activity, beta-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests.
    Barry AL; Thornsberry C; Jones RN; Gavan TL
    Rev Infect Dis; 1985; 7 Suppl 4():S594-604. PubMed ID: 3909316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing.
    Ayers LW; Jones RN; Barry AL; Thornsberry C; Fuchs PC; Gavan TL; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1982 Nov; 22(5):859-77. PubMed ID: 6983862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tentative interpretive standards for agar disk diffusion antimicrobial susceptibility testing of cefoperazone.
    Thornsberry C; Barry AL; Jones RN; Baker CN; Badal RE
    J Clin Microbiol; 1982 May; 15(5):769-76. PubMed ID: 6212595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Criteria for the assessment of susceptibility to ceftazidime using the disc diffusion procedure.
    Grimm H
    Infection; 1983; 11 Suppl 1():S35-8. PubMed ID: 6339416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth-generation cephalosporin, in clinical microbiology laboratories.
    Jones RN; Thornsberry C; Barry AL; Ayers L; Brown S; Daniel J; Fuchs PC; Gavan TL; Gerlach EH; Matsen JM
    J Clin Microbiol; 1984 Sep; 20(3):409-12. PubMed ID: 6490826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antibacterial spectrum of E1040 compared with those of cefpirome and ceftazidime and disk diffusion interpretive criteria for E1040.
    Fuchs PC; Jones RN; Barry AL
    Antimicrob Agents Chemother; 1990 May; 34(5):914-7. PubMed ID: 2193626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the cefonicid disk test criteria, including disk quality control guidelines.
    Barry AL; Jones RN; Thornsberry C
    J Clin Microbiol; 1983 Feb; 17(2):232-9. PubMed ID: 6601113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-strain regression analysis for determination of interpretive breakpoints for cefoperazone disk diffusion susceptibility testing.
    Kronvall G
    J Clin Microbiol; 1983 Jun; 17(6):975-80. PubMed ID: 6223938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility testing of carumonam: interpretive criteria for 30-microgram disk tests and quality control guidelines for disk diffusion and broth microdilution methods.
    Jones RN; Barry AL
    J Clin Microbiol; 1987 Nov; 25(11):2243-6. PubMed ID: 3693552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disk diffusion susceptibility test interpretive criteria for GR69153, a new catechol-substituted cephalosporin.
    Jones RN; Erwin ME
    J Clin Microbiol; 1991 Dec; 29(12):2890-2. PubMed ID: 1757568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of EUCAST zone diameter breakpoints and quality control criteria for ceftazidime-avibactam 10-4 μg.
    Koeth LM; Matuschek E; Kahlmeter G; Stone G
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1047-1053. PubMed ID: 29603034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing.
    Fuchs PC; Barry AL; Thornsberry C; Jones RN; Gavan TL; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1980 Jul; 18(1):88-93. PubMed ID: 6251750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpretive standards and quality control guidelines for cefpiramide disk susceptibility tests.
    Barry AL; Gavan TL; Thornsberry C; Jones RN
    J Clin Microbiol; 1985 Oct; 22(4):688-90. PubMed ID: 4077974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic.
    Fuchs PC; Jones RN; Barry AL
    J Clin Microbiol; 1990 Mar; 28(3):608-9. PubMed ID: 2108997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.